Christina M. Ackermann

Overview

Christina M. Ackermann received an average of $4M in total compensation, including $610K in salary, at Valeant Pharmaceuticals International from 2016 to 2021.

Source: SEC filings on May 2, 2022, March 18, 2019, and March 21, 2018.

Related executives

We found 27 more executives who work or worked at Valeant Pharmaceuticals International.

Joseph Papa

Valeant Pharmaceuticals International

Chief Executive Officer

Thomas Appio

Valeant Pharmaceuticals International

President Co, Head Bausch + Lomb/International

Paul Herendeen

Valeant Pharmaceuticals International

Chief Financial Officer

Sam Eldessouky

Valeant Pharmaceuticals International

Chief Financial Officer

Robert Spurr

Valeant Pharmaceuticals International

President, U.S. Pharma Business

Joseph Gordon

Valeant Pharmaceuticals International

President & Co, Head, Bausch + Lomb/International

William Humphries

Valeant Pharmaceuticals International

Group Chairman

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

News

You may also like